AssetMark Inc’s Terns Pharmaceuticals TERN Stock Holding History

AssetMark Inc’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-16,157	Closed	-$852K	–	3655
2026 Q1	$852K	Buy	+16,157	New	+$664K	﹤0.01%	1066

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AssetMark Inc's TERN Position: Q2 2026 in Review

AssetMark Inc sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 16,157 shares — an estimated $852K sold.

AssetMark Inc first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $852K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

AssetMark Inc reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
AssetMark Inc sold 16,157 Terns Pharmaceuticals shares in Q2 2026, an estimated $852K.
AssetMark Inc first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
AssetMark Inc's Terns Pharmaceuticals position peaked at $852K in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.